Poseida Therapeutics Inc (NASDAQ:PSTX) People

Poseida Therapeutics Inc

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Schmid
Other companies: BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past)
Director · Jul 9, 2020 – Jan 8, 2025 · Past
Rafael G. Amado
Other companies: Zai Lab Ltd. (President, Head of Global Research and Development · Since at least Dec 30, 2022); Allogene Therapeutics, Inc. (EVP of R&D · Sep 3, 2019 – Oct 7, 2022 · Past); Adaptimmune Therapeutics PLC (President, R&D · Jan 1, 2016 – Aug 6, 2019 · Past)
Director · Apr 13, 2023 – Jan 8, 2025 · Past
Sean Murphy
Other companies: TriSalus Life Sciences, Inc. (Director · Since at least Aug 10, 2023); Radius Health, Inc. (Director · Aug 10, 2020 – Aug 15, 2022 · Past); Novan Inc (Director · Sep 20, 2016 – Jun 4, 2018 · Past)
Director · Jul 9, 2020 – Jul 14, 2020 · Past
Harry J Leonhardt
Other companies: Halozyme Therapeutics, Inc. (SVP, GC · Apr 13, 2016 – Apr 13, 2019 · Past)
GC & Chief Compliance Officer · Sep 15, 2020 – Jan 8, 2025 · Past
Marcea Bland Lloyd
Other companies: Amylin Pharmaceuticals LLC (SVP, Chief Administrative Offi · Mar 1, 2011 – Feb 8, 2012 · Past)
Director · Jul 9, 2020 – Jan 8, 2025 · Past
Brent WarnerPresident, Gene Therapy · Feb 21, 2022 – Mar 1, 2024 · Past
Kerry D IngallsChief Operating Officer · Jul 9, 2020 – Mar 16, 2022 · Past
Luke CorningDirector · Dec 16, 2020 – Jan 8, 2025 · Past
Mark J GergenPresident and CEO, Director · Feb 1, 2023 – Jan 8, 2025 · Past